Mycobacterium bovis infection of total hip arthroplasty after intravesicular Bacillus Calmette-Guérin
| Autor: | David P. Gwynne-Jones, Brendan Arnold, Ariane Williams |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2019 |
| Předmět: |
medicine.medical_specialty
Prosthetic joint infection Prosthesis Retention medicine.drug_class medicine.medical_treatment Antibiotics Case Report Attenuated strain 03 medical and health sciences 0302 clinical medicine lcsh:Orthopedic surgery Bacillus Calmette-Guérin medicine Orthopedics and Sports Medicine In patient 030212 general & internal medicine DAIR 030222 orthopedics Mycobacterium bovis Bladder cancer Debridement biology business.industry biology.organism_classification medicine.disease Surgery lcsh:RD701-811 Total hip arthroplasty business |
| Zdroj: | Arthroplasty Today, Vol 5, Iss 4, Pp 416-420 (2019) Arthroplasty Today |
| ISSN: | 2352-3441 |
| Popis: | Intravesicular application of Bacillus Calmette-Guérin (BCG), a live attenuated strain of Mycobacterium bovis, is effective in the treatment of bladder cancer. However, systemic dissemination and subsequent infection of implants have been reported. We present a case of M. bovis infection of a total hip arthroplasty 5 years after BCG instillation for bladder cancer. He was treated with debridement, antibiotics, irrigation, and prosthesis retention with appropriate antituberculous therapy. At 4 years after surgery and 3 years after cessation of treatment, he has had no recurrence of infection with a good functional outcome. This case highlights the need to consider Mycobacteria infection in patients who have received intravesicular BCG. Debridement and retention of well-fixed implants can be successful in combination with appropriate antituberculous therapy. Keywords: Bacillus Calmette-Guérin, Total hip arthroplasty, Prosthetic joint infection, Mycobacterium bovis, DAIR |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|